COMPANY INFO
Amulet, Inc. is a company founded in 2016 by Abigail Barnes, headquartered in Madison, Wisconsin. It operates in the biotechnology industry, specifically providing wearable devices for consumers to detect food allergens. The company has about 22 employees and has raised $5.9 million in funding. Amulet's platform alerts users about allergens in food, aiming to make food a source of fuel rather than fear. Their website is www.amulet-inc.com.
Amulet Inc. is a biotechnology company founded in 2016 by Abigail Barnes and headquartered in Madison, Wisconsin. Specializing in wearable devices for food allergen detection, Amulet Inc. empowers consumers to assess food safety in real time, helping make food a source of fuel instead of fear. With a talented team of about 22 employees, Amulet Inc. operates in the biotechnology research industry and is dedicated to improving health and safety for those with food allergies.
Amulet Inc. funding history demonstrates strategic, milestone-driven growth. To date, Amulet Inc. has raised a total of $5.9 million across several funding rounds, reflecting strong interest from both venture capital investors and grant sources. The company's funding strategy has focused on enabling product development, scaling up its team, expanding its detection portfolio, and supporting full-scale product launches. Amulet Inc. investors include prominent venture capital firms and health-focused organizations, which underscores the company's credibility and potential for market impact.
This Series A round was raised to scale the Amulet Inc. team, expand the allergen detection portfolio, and execute a comprehensive product launch. The funds will support core research, distribution, and market growth activities.
This grant was awarded as prize money to facilitate continued development of Amulet Inc.’s consumer allergen detection solutions.
Another grant prize, allocated for developmental activities and scaling the company's technological capabilities.
Seed funding enabled the initial launch of Amulet Inc., helping to lay the foundation for its allergen detection technology and early operations.
HealthX Ventures is a health-focused venture capital firm, and as a lead Series A investor, HealthX Ventures plays a critical role in scaling Amulet Inc. funding and facilitating its growth in the health tech market.
Incite is an innovation-driven venture capital investor and a lead participant in the Series A round, supporting Amulet Inc. funding rounds as it advances product development and market readiness.
The United States Department of Health and Human Services (HHS) awarded grants to Amulet Inc., providing vital non-dilutive capital to assist with product and platform development.
Great Oaks Venture Capital is an early-stage investor that brings significant support and strategic guidance to Amulet Inc. investment efforts and long-term vision.
Gener8tor is an accelerator program that provided seed capital and critical early-stage mentorship to Amulet Inc., helping launch the company's operations.
Websets is a powerful natural language search and data enrichment tool that helps you discover comprehensive funding information for any company. Whether you're researching Amulet Inc. funding rounds or exploring investment data for other companies, Websets provides detailed insights into funding history, investors, and financial milestones.
With Websets, you can access detailed funding profiles, investor information, and financial data through intuitive natural language queries. Sign up now to enhance your funding research capabilities.